Fatal rhabdomyolysis associated with simvastatin in a renaltransplant patient [3]

American Journal of Medicine

Volumn 108, Issue 4, 2000, Pages 351-352

  Weise, Wolfgang J ^a   Possidente, Carl J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN;

ADULT; CLINICAL ARTICLE; DRUG FATALITY; FEMALE; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RHABDOMYOLYSIS;

ANTILIPEMIC AGENTS; CYCLOSPORINE; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 0033954632     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00320-4     Document Type: Letter

References (5)

1. Deslypere JP, Vermeulen A. Rhabdomyolysis and simvastatin. Ann Intern Med 1991;114:342. Letter.
2. G. Blaison J. Weber D. Sachs Rhabdomyolyse causée par la simvastatine chez un transplanté cardiaque sous cicloporine Rev Med Interne 13 1992 61 63
3. C. Meier C. Stey T. Brack Rhabdomyolyse bei mit Simvastatin und Ciclosporin behandelten Patienten Rolle der Aktivität des Cytochrom-P450-Enzymsystems der Leber Schweiz Med Wochenschr 125 1995 1342 1346
4. M. Arnadottir L.O. Eriksson H. Thysell Plasma concentration profiles of simvastatin 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor activity in kidney transplant recipients with and without cyclosporin Nephron 65 1993 410 413
5. J. Vanhaecke J.V. Cleemput J. Van Lierde Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine Transplantation 58 1994 42 45